237 related articles for article (PubMed ID: 22442150)
1. A fluorescent biosensor reveals conformational changes in human immunoglobulin E Fc: implications for mechanisms of receptor binding, inhibition, and allergen recognition.
Hunt J; Keeble AH; Dale RE; Corbett MK; Beavil RL; Levitt J; Swann MJ; Suhling K; Ameer-Beg S; Sutton BJ; Beavil AJ
J Biol Chem; 2012 May; 287(21):17459-17470. PubMed ID: 22442150
[TBL] [Abstract][Full Text] [Related]
2. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.
Davies AM; Allan EG; Keeble AH; Delgado J; Cossins BP; Mitropoulou AN; Pang MOY; Ceska T; Beavil AJ; Craggs G; Westwood M; Henry AJ; McDonnell JM; Sutton BJ
J Biol Chem; 2017 Jun; 292(24):9975-9987. PubMed ID: 28438838
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody.
Chen JB; Ramadani F; Pang MOY; Beavil RL; Holdom MD; Mitropoulou AN; Beavil AJ; Gould HJ; Chang TW; Sutton BJ; McDonnell JM; Davies AM
Sci Rep; 2018 Aug; 8(1):11548. PubMed ID: 30069035
[TBL] [Abstract][Full Text] [Related]
4. Thermal sensitivity and flexibility of the Cε3 domains in immunoglobulin E.
Doré KA; Davies AM; Drinkwater N; Beavil AJ; McDonnell JM; Sutton BJ
Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1336-1347. PubMed ID: 28844738
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcεRI.
Dhaliwal B; Yuan D; Pang MO; Henry AJ; Cain K; Oxbrow A; Fabiane SM; Beavil AJ; McDonnell JM; Gould HJ; Sutton BJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12686-91. PubMed ID: 22802656
[TBL] [Abstract][Full Text] [Related]
6. Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization.
Mitropoulou AN; Ceska T; Heads JT; Beavil AJ; Henry AJ; McDonnell JM; Sutton BJ; Davies AM
Acta Crystallogr F Struct Biol Commun; 2020 Mar; 76(Pt 3):116-129. PubMed ID: 32133997
[TBL] [Abstract][Full Text] [Related]
7. Structural and Physical Basis for Anti-IgE Therapy.
Wright JD; Chu HM; Huang CH; Ma C; Chang TW; Lim C
Sci Rep; 2015 Jun; 5():11581. PubMed ID: 26113483
[TBL] [Abstract][Full Text] [Related]
8. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
[TBL] [Abstract][Full Text] [Related]
9. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
[TBL] [Abstract][Full Text] [Related]
10. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
[TBL] [Abstract][Full Text] [Related]
11. Structure of the omalizumab Fab.
Jensen RK; Plum M; Tjerrild L; Jakob T; Spillner E; Andersen GR
Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):419-26. PubMed ID: 25849503
[TBL] [Abstract][Full Text] [Related]
12. Ca2+-dependent structural changes in the B-cell receptor CD23 increase its affinity for human immunoglobulin E.
Yuan D; Keeble AH; Hibbert RG; Fabiane S; Gould HJ; McDonnell JM; Beavil AJ; Sutton BJ; Dhaliwal B
J Biol Chem; 2013 Jul; 288(30):21667-77. PubMed ID: 23775083
[TBL] [Abstract][Full Text] [Related]
13. Structure of the human IgE-Fc C epsilon 3-C epsilon 4 reveals conformational flexibility in the antibody effector domains.
Wurzburg BA; Garman SC; Jardetzky TS
Immunity; 2000 Sep; 13(3):375-85. PubMed ID: 11021535
[TBL] [Abstract][Full Text] [Related]
14. The role of Cε2, Cε3, and Cε4 domains in human and canine IgE and their contribution to FcεRIα interaction.
Ye H; Housden JE; Hunter MJ; Sabban S; Helm BA
Mol Immunol; 2014 Feb; 57(2):151-9. PubMed ID: 24091297
[TBL] [Abstract][Full Text] [Related]
15. Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII.
Sutton BJ; Davies AM
Immunol Rev; 2015 Nov; 268(1):222-35. PubMed ID: 26497523
[TBL] [Abstract][Full Text] [Related]
16. An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, nonreceptor binding conformation.
Wurzburg BA; Kim B; Tarchevskaya SS; Eggel A; Vogel M; Jardetzky TS
J Biol Chem; 2012 Oct; 287(43):36251-7. PubMed ID: 22948141
[TBL] [Abstract][Full Text] [Related]
17. The structure of the IgE Cepsilon2 domain and its role in stabilizing the complex with its high-affinity receptor FcepsilonRIalpha.
McDonnell JM; Calvert R; Beavil RL; Beavil AJ; Henry AJ; Sutton BJ; Gould HJ; Cowburn D
Nat Struct Biol; 2001 May; 8(5):437-41. PubMed ID: 11323720
[TBL] [Abstract][Full Text] [Related]
18. Disulfide linkage controls the affinity and stoichiometry of IgE Fcepsilon3-4 binding to FcepsilonRI.
Hunt J; Beavil RL; Calvert RA; Gould HJ; Sutton BJ; Beavil AJ
J Biol Chem; 2005 Apr; 280(17):16808-14. PubMed ID: 15743766
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
[TBL] [Abstract][Full Text] [Related]
20. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.
Kim B; Eggel A; Tarchevskaya SS; Vogel M; Prinz H; Jardetzky TS
Nature; 2012 Nov; 491(7425):613-7. PubMed ID: 23103871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
